Tag: Ceryx Medical
Implantable bioelectronic pacemaker is first device manufactured at new UK hub
Ceryx Medical and King’s College London (London, UK) have announced that the first implantable device has been manufactured at the national facility for the...
Ceryx Medical to develop physiologically responsive pacemaker following funding boost
Ceryx Medical has announced the successful closure of a new funding round, bringing the company’s total raised to US$15 million, with the new investment...
First patient enrolled in trial of Cysoni temporary pacing technology
Ceryx Medical has announced that the first patient has been enrolled in the RSA-Pace multicentre study at Waikato Hospital in Hamilton, New Zealand evaluating...
Trial approved for new pacemaker aiming to boost recovery in heart...
Ceryx Medical has announced the approval of a trial evaluating Cysoni-XT—a new temporary cardiac pacemaker aiming to boost recovery in heart failure.
The UK Medicines...
RSA-pace study of Cysoni-XT temporary pacing system granted approval
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clinical trial authorisation application for the pilot respiratory sinus arrhythmia (RSA)-pace...
Ceryx Medical launches Cysoni bionic device for respiratory sinus arrhythmia
A collaboration between Ceryx Medical Limited and the scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, have developed...